MDNAF
Price
$0.60
Change
-$0.02 (-3.23%)
Updated
Aug 1 closing price
Capitalization
50.65M
6 days until earnings call
VIR
Price
$5.03
Change
-$0.04 (-0.79%)
Updated
Aug 1 closing price
Capitalization
695.34M
4 days until earnings call
Interact to see
Advertisement

MDNAF vs VIR

Header iconMDNAF vs VIR Comparison
Open Charts MDNAF vs VIRBanner chart's image
Medicenna Therapeutics
Price$0.60
Change-$0.02 (-3.23%)
Volume$170.65K
Capitalization50.65M
Vir Biotechnology
Price$5.03
Change-$0.04 (-0.79%)
Volume$809.88K
Capitalization695.34M
MDNAF vs VIR Comparison Chart in %
Loading...
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDNAF vs. VIR commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDNAF is a Hold and VIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (MDNAF: $0.60 vs. VIR: $5.03)
Brand notoriety: MDNAF and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDNAF: 517% vs. VIR: 68%
Market capitalization -- MDNAF: $50.65M vs. VIR: $695.34M
MDNAF [@Biotechnology] is valued at $50.65M. VIR’s [@Biotechnology] market capitalization is $695.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDNAF’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • MDNAF’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than MDNAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDNAF’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • MDNAF’s TA Score: 4 bullish, 3 bearish.
  • VIR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MDNAF is a better buy in the short-term than VIR.

Price Growth

MDNAF (@Biotechnology) experienced а -2.31% price change this week, while VIR (@Biotechnology) price change was -10.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

MDNAF is expected to report earnings on Nov 14, 2025.

VIR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($695M) has a higher market cap than MDNAF($50.7M). VIR YTD gains are higher at: -31.471 vs. MDNAF (-47.598). MDNAF has higher annual earnings (EBITDA): -18.65M vs. VIR (-598.69M). VIR has more cash in the bank: 802M vs. MDNAF (30M). MDNAF has less debt than VIR: MDNAF (174K) vs VIR (96.1M). VIR has higher revenues than MDNAF: VIR (14.3M) vs MDNAF (0).
MDNAFVIRMDNAF / VIR
Capitalization50.7M695M7%
EBITDA-18.65M-598.69M3%
Gain YTD-47.598-31.471151%
P/E RatioN/AN/A-
Revenue014.3M-
Total Cash30M802M4%
Total Debt174K96.1M0%
FUNDAMENTALS RATINGS
MDNAF: Fundamental Ratings
MDNAF
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDNAFVIR
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
67%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSCOX23.18N/A
N/A
Fidelity International Small Cap Opp
OPTFX91.12N/A
N/A
Invesco Discovery Large Cap A
GMXIX16.61N/A
N/A
Nationwide Mid Cap Market Idx R6
MGFSX10.46N/A
N/A
MassMutual Global R5
JSIGX24.21N/A
N/A
Jacob Small Cap Growth Institutional

MDNAF and

Correlation & Price change

A.I.dvisor tells us that MDNAF and LRMR have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDNAF and LRMR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDNAF
1D Price
Change %
MDNAF100%
-2.58%
LRMR - MDNAF
25%
Poorly correlated
-0.58%
VIR - MDNAF
25%
Poorly correlated
-0.79%
STOK - MDNAF
23%
Poorly correlated
+0.47%
CGEM - MDNAF
23%
Poorly correlated
-1.29%
PTCT - MDNAF
22%
Poorly correlated
+0.04%
More